Related Experiment Video
Updated: May 5, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Hyperemic stenosis resistance index for evaluation of functional coronary lesion severity
Martijn Meuwissen1, Maria Siebes, Steven A J Chamuleau
1Departments of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Insights
The hyperemic stenosis resistance index (h-SRv) better predicts reversible perfusion defects than coronary blood flow velocity reserve (CFVR) or fractional flow reserve (FFR). This new index improves assessment of coronary lesion severity, especially when CFVR and FFR results conflict.
Area of Science:
- Cardiovascular physiology
- Interventional cardiology
- Diagnostic imaging
Background:
- Coronary blood flow velocity reserve (CFVR) and fractional flow reserve (FFR) assess coronary lesion severity.
- Discordant results between CFVR and FFR occur in 25-30% of intermediate lesions.
- A combined pressure and flow velocity index may enhance functional assessment.
Purpose of the Study:
- To evaluate the hyperemic stenosis resistance index (h-SRv) for assessing functional coronary lesion severity.
- To compare the predictive value of h-SRv against CFVR and FFR for reversible perfusion defects.
Main Methods:
- 151 angina patients underwent SPECT before cardiac catheterization.
- Coronary pressure and flow velocity were measured in 181 lesions (mean stenosis 56%).
- Hyperemia induced by adenosine; CFVR, FFR, and h-SRv calculated. h-SRv defined as (Aorta Pressure - Distal Pressure) / Peak Flow Velocity.
Main Results:
- Area under the curve (AUC) for h-SRv (0.90±0.03) was significantly higher than for CFVR (0.80±0.04) and FFR (0.82±0.03).
- Agreement with SPECT was higher for h-SRv (73%) compared to CFVR (49%) and FFR (51%) in discordant cases.
- h-SRv demonstrated superior predictive value for reversible perfusion defects.
Conclusions:
- The hyperemic stenosis resistance index (h-SRv) is a more powerful predictor of reversible perfusion defects than CFVR or FFR.
- h-SRv offers improved assessment of functional coronary lesion severity, particularly in cases with discordant CFVR/FFR results.
Background:
Both coronary blood flow velocity reserve (CFVR) and myocardial fractional flow reserve (FFR) are used to evaluate the hemodynamic severity of coronary lesions. However, discordant results between CFVR and FFR have been observed in 25% to 30% of intermediate coronary lesions. An index of stenosis resistance based on a combination of intracoronary pressure and flow velocity may improve the assessment of functional coronary lesion severity.
Methods And Results:
Single photon emission computed tomography (SPECT) was performed in 151 patients with angina to determine reversible perfusion defects within one-week before cardiac catheterization. Coronary pressure and flow velocity was measured distal to 181 single coronary lesions with a mean diameter stenosis of 56% (range: 32% to 85%). Maximum hyperemia was induced by 15 to 20 microg IC adenosine to determine CFVR, FFR, and the hyperemic stenosis resistance index (h-SRv), defined as the ratio of hyperemic stenosis pressure gradient (mean aorta pressure-mean distal pressure) and hyperemic average peak-flow velocity. Receiver-operating-characteristic curves of CFVR, FFR, and h-SRv were calculated to evaluate the predictive value for presence of reversible perfusion defects on SPECT with the use of the area under curve (AUC). The AUC was significantly higher for h-SRv (0.90+/-0.03) compared with those for CFVR (0.80+/-0.04; P=0.024) and FFR (0.82+/-0.03; P=0.018), respectively. Agreement with SPECT was particularly higher (73%) than for CFVR (49%, P=0.022) or FFR (51%, P=0.037) in the group of lesions showing discordant results between CFVR and FFR CONCLUSION: These results indicate that hyperemic stenosis resistance index is a more powerful predictor of reversible perfusion defects than CFVR or FFR.
More Related Videos
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
04:44Author Spotlight: Enhancing Vascular Function and Physical Capacity in Cardiovascular Disease Through Novel Interventions and NIRS Technology
Published on: March 22, 2024
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis IV: Nursing Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies